APR 19, 2021 8:00 AM PDT

Take the Risk out of Rotations: Understanding and Implementing BioSafety Solutions in Centrifugation

Speaker
  • Senior Manager, Biopharma; Beckman Coulter Life Sciences
    Biography

      Derek C. Lenz currently serves as Sr. Marketing Manager, Biopharma at Beckman Coulter Life Sciences, with responsibilities for communicating and educating the marketplace about analytical solutions provided by Beckman Coulter. Prior this role, he served as Biopharma Specialist, where he assists with implementing analytical solutions to application workflows critical in Biopharma research and manufacturing. Previous to Beckman Coulter Life Sciences, Derek spent eight years at Mettler Toledo, initially as an Analytical Instrument Specialist for the Midwest and later as a BioPharma Specialist, supporting operations in North America and Europe. Prior to that, he served as Product Manager for Accuri Cytometers. Dr. Lenz has also held faculty positions at several different universities and colleges, where he taught a range of biological and medical courses and managed research grants and projects, with a number of scientific observations published in peer-reviewed journals. Dr. Lenz holds a Bachelor of Science in Microbiology from The University of Michigan in Ann Arbor, MI. He earned his Doctorate in Immunology, Microbiology & Virology under Dr. Robert Swanborg at Wayne State University School of Medicine in Detroit, MI, and he completed Post-Doctoral Fellowships in Immunology, Microbiology & Virology both at Wayne State University under Dr. Swanborg, and then under Dr. Jonathan Sprent at The Scripps Research Institute in La Jolla, CA.


    Abstract

    Date:  April 19, 2021

    Time: 8:00am PDT, 5:00pm CEST

     

    Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). With the recent and rapid expansion of biopharma and the use of biologics in research and disease treatment, the importance becomes paramount. However, BioSafety should not be viewed from a One-Size-Fits-All perspective; degrees of risk potential vary across laboratory environments. And although oversight organizations define and manage guidance frameworks, the challenge to individual labs and organizations is assessing how to implement, monitor and maintain those standards for their unique environment. In this webinar, Dr. Lenz provides an overview of biosafety from a centrifugation workflow perspective.

     

    Learning Objectives:

    • Evaluate the considerations associated with Biosafety
    • Identify good lab practices in centrifugation BioSafety
    • Describe the levels of containment available with centrifugation
    • Prioritize and implement BioSafety solutions

     

     

     

    Webinars will be available for unlimited on-demand viewing after live event.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    Loading Comments...
    Show Resources
    Attendees
    • See more